These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38160784)

  • 1. Icariin attenuates dopaminergic neural loss in haloperidol-induced Parkinsonism in rats via GSK-3β and tyrosine hydroxylase regulation mechanism.
    Sabry HA; Zahra MM
    J Chem Neuroanat; 2024 Mar; 136():102385. PubMed ID: 38160784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol-induced parkinsonism is attenuated by varenicline in mice.
    Sharma AK; Gupta S; Patel RK; Wardhan N
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):395-401. PubMed ID: 29634484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
    Hedya SA; Safar MM; Bahgat AK
    Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chang HC; Liu KF; Teng CJ; Lai SC; Yang SE; Ching H; Wu CR
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
    Melo JEC; Santos TFO; Santos RS; Franco HS; Monteiro MCN; Bispo JMM; Mendonça MS; Ribeiro AM; Silva RH; Gois AM; Marchioro M; Lins LCRF; Santos JR
    J Chem Neuroanat; 2022 Nov; 125():102162. PubMed ID: 36115503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
    Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
    Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats.
    Xie CL; Lin JY; Wang MH; Zhang Y; Zhang SF; Wang XJ; Liu ZG
    Sci Rep; 2016 Mar; 6():23527. PubMed ID: 26997328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, Biochemical and Histopathological effects of Standardised Pomegranate extract with Vinpocetine, Propolis or Cocoa in a rat model of Parkinson's disease.
    Ali AA; Kamal MM; Khalil MG; Ali SA; Elariny HA; Bekhit A; Wahid A
    Exp Aging Res; 2022; 48(2):191-210. PubMed ID: 34384037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
    Jeon MY; Lee WY; Kang HY; Chung EJ
    Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of haloperidol-induced swim impairment in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease.
    Luthra PM; Barodia SK; Raghubir R
    J Neurosci Methods; 2009 Apr; 178(2):284-90. PubMed ID: 19146880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models.
    Zarrin P; Dehghani Ashkezari M; Seifati SM
    J Mol Neurosci; 2021 Dec; 71(12):2583-2592. PubMed ID: 34125397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO
    Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
    Jones CK; Bubser M; Thompson AD; Dickerson JW; Turle-Lorenzo N; Amalric M; Blobaum AL; Bridges TM; Morrison RD; Jadhav S; Engers DW; Italiano K; Bode J; Daniels JS; Lindsley CW; Hopkins CR; Conn PJ; Niswender CM
    J Pharmacol Exp Ther; 2012 Feb; 340(2):404-21. PubMed ID: 22088953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases.
    Ayadi AE; Zigmond MJ; Smith AD
    Exp Brain Res; 2016 Jul; 234(7):1863-1873. PubMed ID: 26894890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental validation of Vitex negundo leaves hydroalcoholic extract for neuroprotection in haloperidol induced parkinson's disease in rat.
    Vannur A; Biradar PR; Patil V
    Metab Brain Dis; 2022 Feb; 37(2):411-426. PubMed ID: 35023027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
    Güzelad Ö; Özkan A; Parlak H; Sinen O; Afşar E; Öğüt E; Yıldırım FB; Bülbül M; Ağar A; Aslan M
    Metab Brain Dis; 2021 Jun; 36(5):1003-1014. PubMed ID: 33666819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.